(19)
(11) EP 4 172 140 A1

(12)

(43) Date of publication:
03.05.2023 Bulletin 2023/18

(21) Application number: 21734848.1

(22) Date of filing: 24.06.2021
(51) International Patent Classification (IPC): 
C07C 275/26(2006.01)
C07D 239/34(2006.01)
C07D 213/64(2006.01)
A61P 25/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 25/00; C07C 275/26; C07D 213/64; C07D 239/34; C07C 2601/04
(86) International application number:
PCT/EP2021/067288
(87) International publication number:
WO 2021/260090 (30.12.2021 Gazette 2021/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.06.2020 WO PCT/EP2020/067903

(71) Applicant: Idorsia Pharmaceuticals Ltd
4123 Allschwil (CH)

(72) Inventors:
  • BEZENCON, Olivier
    4123 Allschwil (CH)
  • DEYMIER, Caroline
    4123 Allschwil (CH)
  • PETERS, Jens-Uwe
    4123 Allschwil (CH)
  • SIEGRIST, Romain
    4123 Allschwil (CH)
  • SURIVET, Jean-Philippe
    4123 Allschwil (CH)

(74) Representative: Koberstein, Ralf 
Idorsia Pharmaceuticals Ltd Hegenheimermattweg 91
4123 Allschwil
4123 Allschwil (CH)

   


(54) CYCLOBUTYL-UREA DERIVATIVES